Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-556-6 | CAS number: 63-37-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1980
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 980
- Report date:
- 1980
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- - Principle of test: To evaluate the oral acute toxicity of a substance.
- Short description of test conditions: The test substance is administered orally by gavage in graduated doses to several groups of experimental animals, one dose being used per group. After administration, observations of effects and deaths are made for 7 days.
- Parameters analysed / observed: Mortality and adverse effects produced after the administration of the substance. - GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Citicoline
- EC Number:
- 213-580-7
- EC Name:
- Citicoline
- Cas Number:
- 987-78-0
- Molecular formula:
- C14H26N4O11P2
- IUPAC Name:
- (2-{[({[(2R, 3S, 4R, 5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl] methyl phosphonato}oxy)(hydroxy)phosphoryl]oxy}ethyl)trimethylazanium
- Details on test material:
- Synonym: CDP-Choline
Constituent 1
Test animals
- Species:
- rat
- Strain:
- not specified
- Sex:
- male
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Doses:
- 11520, 14400, 18000 and 22500 mg/kg.
- No. of animals per sex per dose:
- 10
- Control animals:
- yes
Results and discussion
Effect levels
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 18 501 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 16 590 - < 21 213
- Mortality:
- After 7 days, deaths were observed at doses 14400 (1), 18000 (5) and 22500 (8) mg/kg bw. In most animals, death occurred between 2 and 48 hours after administration.
- Clinical signs:
- other: Toxicological signs were sedation, convulsion, dyspnea, lacrimation, and collapse. This signs were severer in the dead animals and some of them continued until the death.
Any other information on results incl. tables
Table 1. Acute toxicity of citicoline at day 7 after single administration on male rats.
Dosage (mg/kg) p.o. |
Distribution of dead animals |
Mortality |
LD50 Values (mg/kg) (95% confidence limits) |
|||||||
30 min. |
1 |
2 |
3 |
4 |
5 |
6 |
7 days |
|||
22500 |
0 |
8 |
0 |
0 |
0 |
0 |
0 |
0 |
8/10 |
18501 (16590 – 21213) |
18000 |
0 |
4 |
1 |
0 |
0 |
0 |
0 |
0 |
5/10 |
|
14400 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1/10 |
|
11520 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0/10 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The LD50 of Citicoline is 18501 mg/kg body weight by oral route in male rats.
- Executive summary:
An acute toxicity study of Citicoline has been published. Following a method similar to OECD Guideline 401, 10 male rats were administered orally with 11520, 14400, 18000 and 22500 mg/kg bw of citicoline. After 7 days, mortality was observed at all doses except for the lowest. In most animals, death occurred between 2 and 48 hours after administration. Toxicological signs were sedation, convulsion, dyspnea, lacrimation, and collapse, which were severer in the dead animals and some of them continued until the death. According to the results, the LD50 of Citicoline is 18501 mg/kg body weight by oral route in male rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
